6 questions answered from cited research · Plain language
Yes, multiple studies and meta-analyses consistently identify pleural effusion as an independent risk factor for refractory Mycoplasma pneumoniae pneumonia in children.
Read the full answer →Doctors can predict refractory Mycoplasma pneumoniae pneumonia in children using specific signs like long fever duration, lung complications like pleural effusion, and high levels of inflammatory markers like CRP and LDH.
Read the full answer →Yes, atopic constitution is linked to severe Mycoplasma pneumoniae pneumonia in children, with 74.8% of affected children having atopy and 7.1% progressing to severe disease.
Read the full answer →Yes, a case report can describe necrotizing laryngotracheobronchitis after Mycoplasma pneumoniae pneumonia, as shown in a detailed case of a 7-year-old boy.
Read the full answer →Key predictors of refractory Mycoplasma pneumoniae pneumonia in children include prolonged fever, high CRP, high neutrophil-to-lymphocyte ratio, pleural effusion, atelectasis, and extrapulmonary complications.
Read the full answer →Yes, switching from azithromycin to doxycycline can help children with Mycoplasma pneumoniae pneumonia, especially when macrolide resistance is suspected or the child does not improve after 72 hours of azithromycin.
Read the full answer →